Developing a new device for continuously recording, in vivo, the excretion rate of sweat (perspiration) in humans.


Journal

Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI)
ISSN: 1600-0846
Titre abrégé: Skin Res Technol
Pays: England
ID NLM: 9504453

Informations de publication

Date de publication:
Jul 2019
Historique:
received: 11 07 2018
revised: 30 10 2018
accepted: 09 12 2018
pubmed: 14 2 2019
medline: 25 1 2020
entrez: 14 2 2019
Statut: ppublish

Résumé

Some methodologies used for evaluating sweat production and antiperspirants are of a stationary aspect, that is, most often performed under warm (38°C) but resting conditions in a rather short period of time. The aim is to develop an electronic sensor apt at continuously recording sweat excretion, in vivo, during physical exercises, exposure to differently heated environments, or any other stimuli that may provoke sweat excretion. A sensor (20 cm In vitro calibration, using a NaCl 0.5% solution, allows changes in mV to be related with progressively increased volumes. In vivo, results show that casual physical exercise leads to sweat excretions much higher than in warm environment (37 or 45°C). Only, an exposure to a 50°C environment induced comparable sweat excretion. In this condition, sweat excretions were found similar in both armpits and both genders. Decreased sweat excretions were recorded following applications of ACH, with a dose effect. Developing phases of this new approach indicate that usual method or guidelines used to determine sweat excretions in vivo do not reflect true energy expenditure processes. As a consequence, they probably over-estimate the efficacy of antiperspirant agents or formulae.

Sections du résumé

BACKGROUND BACKGROUND
Some methodologies used for evaluating sweat production and antiperspirants are of a stationary aspect, that is, most often performed under warm (38°C) but resting conditions in a rather short period of time. The aim is to develop an electronic sensor apt at continuously recording sweat excretion, in vivo, during physical exercises, exposure to differently heated environments, or any other stimuli that may provoke sweat excretion.
MATERIAL AND METHODS METHODS
A sensor (20 cm
RESULTS RESULTS
In vitro calibration, using a NaCl 0.5% solution, allows changes in mV to be related with progressively increased volumes. In vivo, results show that casual physical exercise leads to sweat excretions much higher than in warm environment (37 or 45°C). Only, an exposure to a 50°C environment induced comparable sweat excretion. In this condition, sweat excretions were found similar in both armpits and both genders. Decreased sweat excretions were recorded following applications of ACH, with a dose effect.
CONCLUSION CONCLUSIONS
Developing phases of this new approach indicate that usual method or guidelines used to determine sweat excretions in vivo do not reflect true energy expenditure processes. As a consequence, they probably over-estimate the efficacy of antiperspirant agents or formulae.

Identifiants

pubmed: 30758876
doi: 10.1111/srt.12677
doi:

Substances chimiques

Antiperspirants 0

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

489-498

Informations de copyright

© 2019 John Wiley & Sons A/S Published by John Wiley & Sons Ltd.

Auteurs

Elisa Caberlotto (E)

L'Oréal Research and Innovation, Chevilly-Larue, France.

Carole Guillou (C)

L'Oréal Research and Innovation, Chevilly-Larue, France.

Loic Colomb (L)

L'Oréal Research and Innovation, Chevilly-Larue, France.

Charlie Barla (C)

L'Oréal Research and Innovation, Chevilly-Larue, France.

Samir Salah (S)

L'Oréal Research and Innovation, Chevilly-Larue, France.

Marco Vicic (M)

L'Oréal Research and Innovation, Chevilly-Larue, France.

Frederic Revol-Cavalier (F)

CEA, LETI, Univ. Grenoble Alpes, Grenoble, France.

Venceslass Rat (V)

CEA, LETI, Univ. Grenoble Alpes, Grenoble, France.

Sabine Filipe (S)

CEA, LETI, Univ. Grenoble Alpes, Grenoble, France.

Frederic Flament (F)

L'Oréal Research and Innovation, Chevilly-Larue, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH